Skip to content

Clinical trials

Completed Heart Diseases trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Status: Completed Country / region: New Zealand Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20111
20121
20171
20181
20191
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardurion Pharmaceuticals, Inc.2
GlaxoSmithKline2
Amarin Pharma Inc.1
CSL Behring1
Eidos Therapeutics, a BridgeBio company1
KAI Pharmaceuticals1
NYU Langone Health1
Novartis Pharmaceuticals1
Rutgers, The State University of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases11
Cardiovascular Diseases9
Coronary Disease4
Acute Coronary Syndrome3
Atherosclerosis3
Coronary Artery Disease3
Heart Failure3
Myocardial Ischemia3
Myocardial Infarction2
Alzheimer Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.